Bristol-Myers Squibb succession
Executive Summary
Confirmation of Wayne Davidson as the top pharmaceutical officer in the combined businesses has rekindled interest in the post-Gelb management. Chairman Richard Gelb has set June 1993 as the target for his retirement. At that date, current Vice Chairman William Miller will be 64. Likely replacement will come from current triumverate of exec VPs: Davidson, Charles Heimbold and Michael Autera. Heimbold, 56, has responsibility for consumer products, the health care group (medical devices) and planning and development. Autera is chief financial officer and head of administration, a key post in a major merger period.